INR 7.5: Does It Require Transfusion? Clinical Decision Guide

An INR of 7.5 is significantly elevated (therapeutic range is typically 2.0–3.0). Management depends on clinical context, not the number alone.

Key Decision Factors

  • Active bleeding: Major bleeding → urgent 4-factor PCC (preferred) + IV vitamin K 10mg. Life-threatening → PCC over FFP.
  • No bleeding: Hold anticoagulant; give oral/IV vitamin K (1–5mg) based on INR level and thrombosis risk. FFP not indicated for asymptomatic elevation.
  • Anticoagulation indication: Mechanical mitral valve (target INR 2.5–3.5) vs. atrial fibrillation (2.0–3.0) — reversal thresholds differ.
  • Comorbidities: Liver disease, malnutrition, drug interactions (antibiotics, amiodarone).
  • Rate of rise: Acute vs. chronic elevation.

Guideline Summary (ACC/CHEST)

  • INR 4.5–10, no bleeding: Hold warfarin; consider oral vitamin K 1–2.5mg.
  • INR >10, no bleeding: Hold warfarin; oral vitamin K 2.5–5mg.
  • Any major bleeding: 4F-PCC + IV vitamin K 10mg (rapid reversal).

Never self-manage. Contact the prescribing clinician or anticoagulation clinic immediately.

Blood Disorders - Related Articles